Search Results

There are 9302 results for: content related to: Future Directions in the Oncological Treatment of Colorectal Cancer

  1. Clinical application of oxaliplatin in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1717–1732, S. FU, J.J. KAVANAGH, W. HU and R.C. BAST Jr

    Article first published online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00654.x

  2. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  3. Effects of oxaliplatin and oleic acid Gc-protein-derived macrophage-activating factor on murine and human microglia

    Journal of Neuroscience Research

    Volume 93, Issue 9, September 2015, Pages: 1364–1377, Jacopo J.V. Branca, Gabriele Morucci, Francesca Malentacchi, Stefania Gelmini, Marco Ruggiero and Stefania Pacini

    Article first published online : 18 MAR 2015, DOI: 10.1002/jnr.23588

  4. SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients

    International Journal of Cancer

    Accepted manuscript online: 2 FEB 2016, Elisabeth J. Kap, Petra Seibold, Dominique Scherer, Nina Habermann, Yesilda Balavarca, Lina Jansen, Manuela Zucknick, Natalia Becker, Michael Hoffmeister, Alexis Ulrich, Axel Benner, Cornelia M Ulrich, Barbara Burwinkel, Hermann Brenner and Jenny Chang-Claude

    DOI: 10.1002/ijc.30026

  5. Chemotherapy of Advanced Colorectal Cancer

    Challenges in Colorectal Cancer

    John H. Scholefield, Axel Grothey, Herand Abcarian, Tim Maughan, Pages: 195–212, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753231.ch13

  6. Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells

    Environmental and Molecular Mutagenesis

    Volume 46, Issue 2, 2005, Pages: 104–115, Maria J. Silva, Paula Costa, Anabela Dias, Marco Valente, Henriqueta Louro and Maria G. Boavida

    Article first published online : 10 MAY 2005, DOI: 10.1002/em.20138

  7. You have free access to this content
    Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer

    Cancer

    Volume 118, Issue 17, 1 September 2012, Pages: 4309–4320, Hanna K. Sanoff, William R. Carpenter, Janet Freburger, Ling Li, Kun Chen, Leah L. Zullig, Richard M. Goldberg, Maria J. Schymura and Deborah Schrag

    Article first published online : 31 JAN 2012, DOI: 10.1002/cncr.27422

  8. Real-world resource use and costs of adjuvant treatment for stage III colon cancer

    European Journal of Cancer Care

    Volume 24, Issue 3, May 2015, Pages: 321–332, C.W.M. van Gils, S. de Groot, S.S. Tan, W.K. Redekop, M. Koopman, C.J.A. Punt and C.A. Uyl-de Groot

    Article first published online : 25 DEC 2013, DOI: 10.1111/ecc.12154

  9. A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors

    Pediatric Blood & Cancer

    Volume 60, Issue 2, February 2013, Pages: 230–236, Margaret E. Macy, Tracey Duncan, James Whitlock, Stephen P. Hunger, Jessica Boklan, Aru Narendran, Cynthia Herzog, Robert J. Arceci, Rochelle Bagatell, Tanya Trippett, Uwe Christians, Katherine Rolla, S. Percy Ivy, Lia Gore and on behalf of the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC)

    Article first published online : 28 SEP 2012, DOI: 10.1002/pbc.24278

  10. You have free access to this content
    Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients

    Cancer

    Volume 118, Issue 12, 15 June 2012, Pages: 3173–3181, C. Daniel Mullins, Fei-Yuan Hsiao, Eberechukwu Onukwugha, Naimish B. Pandya and Nader Hanna

    Article first published online : 21 OCT 2011, DOI: 10.1002/cncr.26613

  11. You have free access to this content
    Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01

    Cancer

    Volume 118, Issue 22, 15 November 2012, Pages: 5614–5622, Kelley M. Kidwell, Greg Yothers, Patricia A. Ganz, Stephanie R. Land, Clifford Y. Ko, Reena S. Cecchini, Jacek A. Kopec and Norman Wolmark

    Article first published online : 8 MAY 2012, DOI: 10.1002/cncr.27593

  12. Systemic Treatment of Hepatobiliary Tumors

    Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

    Panagiotis Samaras, Michael A. Morse, Bernhard C. Pestalozzi, Pages: 107–121, 2009

    Published Online : 9 DEC 2009, DOI: 10.1002/9781444317053.ch10

  13. Cancer of the Colon and Rectum

    Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

    Rachel S. Midgley, Omar Khan, Andrew Weaver, Daniel Royston, Bryan Warren, Margaret Betts, Baljit Singh, Chris Cunningham, Ami Sabharwal, David Kerr, Robert Glynne-Jones, Zahir Soonwalla, Fergus Gleeson, Carlos Escriu, Mark Middleton, Ann MacArthur, Julia Liddi, Pages: 325–373, 2009

    Published Online : 14 JAN 2009, DOI: 10.1002/9781444300147.ch14

  14. Clinical Use of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 11P2, November 2008, Pages: 31S–41S, Dina K. Patel

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.28.11-supp.31S

  15. PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects

    International Journal of Cancer

    Volume 137, Issue 1, 1 July 2015, Pages: 243–250, Masanobu Tsubaki, Tomoya Takeda, Tadahumi Tani, Hirotaka Shimaoka, Naohiro Suzuyama, Kotaro Sakamoto, Arisa Fujita, Naoki Ogawa, Tatsuki Itoh, Motohiro Imano, Yoshinori Funakami, Seiji Ichida, Takao Satou and Shozo Nishida

    Article first published online : 8 DEC 2014, DOI: 10.1002/ijc.29367

  16. Pharmacokinetics of intraperitoneal oxaliplatin: Experimental studies

    Journal of Surgical Oncology

    Volume 76, Issue 2, February 2001, Pages: 106–114, Sophie R. Pestieau, Jim F. Belliveau, Hank Griffin, O. Anthony Stuart and Paul H. Sugarbaker

    Article first published online : 14 FEB 2001, DOI: 10.1002/1096-9098(200102)76:2<106::AID-JSO1020>3.0.CO;2-E

  17. A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin

    European Journal of Cancer Care

    Volume 24, Issue 1, January 2015, Pages: 111–116, H. Yamauchi, T. Goto, K. Takayoshi, K. Sagara, M. Uoi, C. Kawanabe, M. Matsunaga, T. Miyoshi, K. Uchino, N. Misumi and T. Nishino

    Article first published online : 5 DEC 2013, DOI: 10.1111/ecc.12156

  18. Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy

    Asia-Pacific Journal of Clinical Oncology

    Volume 6, Issue 4, December 2010, Pages: 270–277, Wen-Yee CHAY, Sze-Huey TAN, Yew-Long LO, Simon Yew-Kwang ONG, Hui-Cheng NG, Fei GAO, Wen-Hsin KOO and Su-Pin CHOO

    Article first published online : 30 NOV 2010, DOI: 10.1111/j.1743-7563.2010.01344.x

  19. Evidence-based update of chemotherapy options for metastatic colorectal cancer

    ANZ Journal of Surgery

    Volume 74, Issue 9, September 2004, Pages: 781–787, Dragan Damjanovic, Paul Thompson and Michael P. N. Findlay

    Article first published online : 20 SEP 2004, DOI: 10.1111/j.1445-1433.2004.03148.x

  20. You have free access to this content
    Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults

    Cancer

    Volume 118, Issue 11, 1 June 2012, Pages: 2925–2934, Christina D. Mack, William Carpenter, Anne-Marie Meyer, Hanna Sanoff and Til Stürmer

    Article first published online : 9 NOV 2011, DOI: 10.1002/cncr.26622